Competitive: ICON Plc: ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - PHARMABIZ.COM - A la Une - 12/Jul 00:00
BioStem Technologies receives IRB nod to advance clinical study to evaluate AmnioWrap2 in diabetic foot ulcers
BioStem Technologies Inc, a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental─derived biologics for advanced wound care, announced that the
Articles similaires
ICON Strategic Solutions: Clinical Research Associate
pharmiweb.com - 19/Aug 00:00
Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...
ICON Plc: CRA II / Senior CRA
pharmiweb.com - 10/Aug 00:00
Competitive: ICON Plc: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance...
ICON Strategic Solutions: CRA II
pharmiweb.com - 16/Aug 00:00
Competitive: ICON Strategic Solutions: ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...
ICON Strategic Solutions: CRA II
pharmiweb.com - 00:00
Competitive: ICON Strategic Solutions: I CON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to...
PharmaDrug Joint Venture Receives Approval For Phase 1 Clinical Trial
thedeepdive.ca - 19/Aug 13:08
Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics, to process with a Phase 1 clinical study...
CHASE: Clinical Strategy Manager - South West England
pharmiweb.com - 19/Aug 15:23
Competitive Salary and Bonus: CHASE: Clinical Strategy Manager - Advanced Wound Care - South West England England
CHASE: Clinical Strategy Manager - North London & Hertfordshire
pharmiweb.com - 19/Aug 15:23
Competitive Salary and Bonus: CHASE: Clinical Strategy Manager - Advanced Wound Care - North London & Hertfordshire London, England, North London
Les derniers communiqués
-
Aucun élément